Graves Disease Epidemiology Forecast to 2032: Focus on 7 Major Markets - United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com

The "Graves Disease - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.

This "Graves Disease - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Graves Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Graves Disease Epidemiology Perspective

The Graves Disease epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Graves Disease epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM.

The Graves Disease epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Graves Disease Detailed Epidemiology Segmentation

The Graves Disease epidemiology covered in the report provides historical as well as forecasted Graves Disease epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

The Graves Disease report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

KOL views

The publisher interviews, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Scope of the Report

• The Graves Disease report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The Graves Disease Epidemiology Report and Model provide an overview of the global trends of Graves Disease in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Graves Disease in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM for the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Graves Disease
• The report provides the segmentation of the Graves Disease epidemiology

Report Highlights

• 11-year Forecast of Graves Disease epidemiology
• 7MM Coverage
• Prevalent and Diagnosed Cases of Graves Disease
• Cases of Graves Disease by Mutation Types
• Graves Disease Cases associated with Clinical Manifestations

Key Assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Key Topics Covered:

1. Key Insights

2. Executive Summary of Graves Disease

3. Graves Disease: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Graves Disease Epidemiology Scenario in the 7MM (2019-2032)

5.4. United States Epidemiology

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.2. France Epidemiology

5.5.3. Italy Epidemiology

5.5.4. Spain Epidemiology

5.5.5. United Kingdom Epidemiology

5.6. Japan Epidemiology

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Graves Disease Treatment and Management

6.2. Graves Disease Treatment Algorithm

7. KOL Views

8. Unmet Needs

9. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/smqvni

View source version on businesswire.com: https://www.businesswire.com/news/home/20220808005523/en/